PNPLA3 and metabolic dysfunction-associated steatotic liver disease: Given the relevance of our new data regarding reduced blood LAL activity after a fatty meal in patients with MASLD, as a second aim of our study, we wanted to verify whether this was associated with the PNPLA3 polymorphism [4].